The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose significant challenges for vaccine development. AIDS vaccine design requires a scientifically driven, rational approach that encompasses the latest advances in viral molecular genetics, structural biology, and immunology
One of the big roadblocks in development of HIV-1/AIDS vaccines is the enormous diversity of HIV-1, ...
Development of an effective AIDS vaccine is a global priority. However, the extreme diversity of HIV...
A central obstacle to the design of a global HIV vaccine is viral diversity. Antigenic differences i...
The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose si...
One of the great demands and challenges for vaccination is to successfully target the pathogens resp...
HIV/AIDS remains one of the most important current threats to global public health. Since its identi...
The extraordinary variability of HIV-1 poses a major obstacle to vaccine development. The effectiven...
Development of an effective AIDS vaccine is a global priority. However, the extreme diversity of HIV...
Numerous human immunodeficiency virus (HIV)-1 vaccines have been developed over the last three decad...
HIV/AIDS is a leading cause of mortality and morbidity worldwide. In spite of successful interventio...
We discuss a recent Nature Medicine publication by Philip Johnson and co-workers (Vector-mediated ge...
On April 23, 1984, the prominent scientist Robert Gallo held a historical press conference at the De...
The ability of human immunodeficiency virus type 1 (HIV-1) to develop high levels of genetic diversi...
Many efforts have been made in the worldwide quest for a prophylactic HIV vaccine to end the AIDS pa...
Development of a preventive vaccine for HIV is the best hope of controlling the AIDS pandemic. HIV ...
One of the big roadblocks in development of HIV-1/AIDS vaccines is the enormous diversity of HIV-1, ...
Development of an effective AIDS vaccine is a global priority. However, the extreme diversity of HIV...
A central obstacle to the design of a global HIV vaccine is viral diversity. Antigenic differences i...
The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose si...
One of the great demands and challenges for vaccination is to successfully target the pathogens resp...
HIV/AIDS remains one of the most important current threats to global public health. Since its identi...
The extraordinary variability of HIV-1 poses a major obstacle to vaccine development. The effectiven...
Development of an effective AIDS vaccine is a global priority. However, the extreme diversity of HIV...
Numerous human immunodeficiency virus (HIV)-1 vaccines have been developed over the last three decad...
HIV/AIDS is a leading cause of mortality and morbidity worldwide. In spite of successful interventio...
We discuss a recent Nature Medicine publication by Philip Johnson and co-workers (Vector-mediated ge...
On April 23, 1984, the prominent scientist Robert Gallo held a historical press conference at the De...
The ability of human immunodeficiency virus type 1 (HIV-1) to develop high levels of genetic diversi...
Many efforts have been made in the worldwide quest for a prophylactic HIV vaccine to end the AIDS pa...
Development of a preventive vaccine for HIV is the best hope of controlling the AIDS pandemic. HIV ...
One of the big roadblocks in development of HIV-1/AIDS vaccines is the enormous diversity of HIV-1, ...
Development of an effective AIDS vaccine is a global priority. However, the extreme diversity of HIV...
A central obstacle to the design of a global HIV vaccine is viral diversity. Antigenic differences i...
DOI
Add to ORKG